•
Helixworks Technologies • 4m
Can Sequencing replace traditional diagnostics in India? Traditional diagnostics are slow. Culture and antibiotic resistance tests take days or even weeks to deliver results. This can be detrimental for patients suffering from sepsis or fever of unknown origin. Meanwhile, sequencing technology has evolved to the point where it can identify both the pathogen and its antibiotic resistance in a single test. Technical challenges include cost, sample prep complexity, and the need for skilled workforce in labs. Business challenges include competing for distribution with established brands like Lal path, MedGenome. On the flip side, sequencing offers massive sample multiplexing, lower turnaround time, and better diagnostic accuracy. I believe there’s potential to build a 100cr revenue business just for infectious disease testing within 3-5 yrs. The same sequencing platform can also be expanded to other areas like liquid biopsy testing, creating further opportunities.
•
Helixworks Technologies • 3m
Looking to connect with folks in clinical diagnostics and molecular biology! I’m building a new clinical lab focused on infectious disease diagnostics powered by DNA sequencing — and would love to connect with people who have experience in: • Runni
See More•
Helixworks Technologies • 4m
Why qPCR & Phenotypic Testing Must Be Displaced? – Part III This is the third part of a deep dive into why qPCR & phenotypic testing need to be replaced. In Part I, I covered the limitations of current diagnostics & why incremental improvements aren
See More•
Helixworks Technologies • 4m
Why qPCR & Phenotypic Testing Must Be Displaced – Part II If you ever want to understand the scale of a problem, look at how much it costs. Tuberculosis alone costs India, Africa, and Brazil 27 trillion INR a year in lost productivity and healthcare
See More•
Helixworks Technologies • 4m
Why qPCR & phenotypic testing must be displaced? - Part I The Problem: Infectious diseases remain a significant public health threat. Particularly, in low and middle-income countries (LMICs), such as India. €300 Billion / 27 Trillion INR! {1} - Th
See MoreNGO ReSehat Sabke Li... • 2m
Sehat Sabke Liye – Diagnostic & Medicine Network Slide 1: Title Sehat Sabke Liye Affordable Healthcare for Every District in UP Presented by: Dr. Mohammed Nadeem Slide 2: Vision & Mission Vision: Sabko sahi ilaj aur sasti dawa sahi samay par mile M
See MoreDownload the medial app to read full posts, comements and news.